MCG for Non-Obstructive Myocardial Ischemia
ConditionMyocardial Ischemia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorQilu Hospital of Shandong University
About this trial
The aim of this prospective study is to identify Non-Obstructive Myocardial Ischemia of patients who have acute chest pain using Magnetocardiography.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 years or older;
Patients with symptoms of myocardial ischemia such as angina pectoris, who have CAG showing <70% stenosis at the most severe site or CTA showing non-severe stenosis
Signed informed consent.
Disqualifiers
Patients with absolute or relative contraindications to CFR-loaded myocardial perfusion, including acute myocardial infarction within 48 hours, significant left main coronary artery stenosis, bronchial asthma, and adenosine injection allergy;
Patients with Non-ischemic dilated cardiomyopathy, or hypertrophic cardiomyopathy, or moderate or severe valvular disease;
Patients with Hemodynamic instability (systolic blood pressure<90 mmHg, or who requires vasoactive drugs), or patients with tachyarrhythmia,
Patients who have severe renal abnormality with eGFR <30 ml/min, or patients who are on dialysis;
Trial population
patient who suffers from cardiogenic chest pain suspected with Non-Obstructive Myocardial Ischemia
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Magnetocardiography
DeviceAssessing the performance of magnetocardiography device for detecting non-obstructive myocardial ischemia using ultrasound coronary flow reserve (CFR) as the reference standard.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Efficacy of MCG for the detection of Non-Obstructive Myocardial Ischemia
Establishing an algorithm model of MCG in identifying Non-Obstructive Myocardial Ischemia, the efficacy of the model was assessed by sensitivity, specificity
Time frame
from the date of enrollment until the date of discharge, up to 30 days]Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov